Bone and Joint Infection, Staphylococcus Aureus
Conditions
Keywords
Bone and Joint Infection, Staphylococcus Aureus, chronic infection
Brief summary
The aim of this study is to determine if delta-haemolysin production deficiency of Staphylococcus aureus is a marker in favour of chronic infections on implants
Interventions
OTHERDelta-haemolysin
comparison of groups having infection with S. aureus with and without delta-haemolysin Production
Sponsors
Hospices Civils de Lyon
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Inclusion criteria
* patients having implant infection due to S. aureus treated by DAIR
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of infection with or witout delta-haemolysin in Staphylococcus Aureus | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption | patients, profile of the bacterium, medical and chirurgical treatment, rate. comparison between the 2 groups |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of Treatment Failure | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption | Treatment failure is defined by local clinical and/or microbiological relapse; and/or need for additional surgery; death of septic origin. Analyse of risk factor. Comparison between the 2 groups |
Countries
France
Contacts
Primary ContactJohanna Boulant, CRA
Outcome results
None listed